Target intelligence / Profile preview

Allogeneic induced pluripotent stem cell-derived motor neuron progenitor cells (iPSC-MNPCs) (iPSC-MNPCs)

Target
iPSC-MNPCs
Molecular classification
Cell therapy, Regenerative medicine, Stem cell-derived therapy
01

Overview

Allogeneic induced pluripotent stem cell-derived motor neuron progenitor cells (iPSC-MNPCs) are a cellular therapeutic modality designed to address the loss of motor neurons in neurodegenerative conditions such as Amyotrophic Lateral Sclerosis (ALS) (Nizzardo et al., 2014, Human Molecular Genetics). These cells are generated by reprogramming adult somatic cells into a pluripotent state and then directionally differentiating them into specialized progenitors committed to the motor neuron lineage (Takahashi & Yamanaka, 2006, Cell). Unlike conventional drugs, iPSC-MNPCs do not interact with a single molecular receptor; instead, they act as a multi-functional replacement therapy. Their primary mechanism involves engraftment into the host spinal cord, where they differentiate into mature neurons, extend axons toward muscle targets, and integrate into the host's neural circuitry to restore motor function (Sivadasan et al., 2018, Progress in Brain Research). Furthermore, these cells provide a bio-factory effect, secreting various neurotrophic factors that enhance the survival of remaining endogenous motor neurons and modulate the local inflammatory environment (Goutman et al., 2019, Molecular Neurodegeneration). Clinical development of these therapies focuses on ensuring the safety of the cells, particularly regarding their purity and the absence of undifferentiated pluripotent cells that could cause tumors. Because these cells are allogeneic, they typically require the co-administration of immunosuppressive drugs to prevent host-versus-graft rejection. This approach represents a paradigm shift from slowing disease progression to potentially regenerating lost neural pathways.

Other names
Allogeneic iPSC-derived motor neuron progenitorsiPSC-MNPCsMotor neuron progenitor cellsiPSC-derived neural progenitor cellsNo discrete molecular target
02

Mechanism of action

The therapeutic effect is achieved through the physical replacement of degenerated motor neurons via engraftment and differentiation into mature neurons that integrate into host neural circuits, alongside the secretion of neurotrophic factors (e.g., BDNF, GDNF) to support endogenous cell survival and modulate neuroinflammation (Nizzardo et al., 2014; Sivadasan et al., 2018).

03

Biological functions

Neural circuit integrationEngraftmentNeuroprotectionSynaptogenesisCell differentiation
04

Disease associations

Amyotrophic lateral sclerosisSpinal muscular atrophySpinal cord injuryMotor neuron disease
05

Safety considerations

Tumorigenicity (teratoma formation)Immune rejection (host-versus-graft response)Ectopic tissue formationSurgical complications of intraspinal injectionGraft-induced abnormal circuit formation
06

Interacting drugs

Tacrolimus

3 more in the full profile.

07

Biomarkers

Neurofilament light chain (NfL)Motor Unit Number Estimation (MUNE)Electromyography (EMG)Compound Muscle Action Potential (CMAP)

Beyond the preview

Go deeper on Allogeneic induced pluripotent stem cell-derived motor neuron progenitor cells (iPSC-MNPCs) (iPSC-MNPCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allogeneic induced pluripotent stem cell-derived motor neuron progenitor cells (iPSC-MNPCs) (iPSC-MNPCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call